EC.1. Lab service time parameters

EC.2. Transportation model regression output
.2 shows the regression output for the model specified in (2) and (3), estimated using the Mozambique data. The coefficients are calculated using the tobit function in Stata/IC R ⃝ 12.1.
The groups correspond to those discussed in §4.1.2and represented in Figure 4 . The reason the regression includes 9 groups as opposed to the 6 in the figure is that we allow the coefficients for groups 1, 2, 3 in the region of Gaza to differ from the rest. This is due to the Gaza samples not being transported by air, as is generally the rule, but by car to Maputo, from where they are flown to their destination. By conducting joint F tests on the β 1,g variables on the one hand and the β 2,i variables on the other we conclude that each set is jointly significant at the the 0.1%. 
Second, we substitute this approximation into Sakasegawa's approximation for E[Q] GI/G/c , the average queue length in a queue with general arrivals, general service times, and c servers;
Third, we incorporate this approximation in Hanschke's approximation for the average number of customers in a ∑ i∈I j
/ c queueing system (eqn. 15 in Hanschke (2006));
Finally, we apply Little's law to approximate the sojourn times in such a system, and add the expected post-processing delay.
e-companion to Deo, Gallien, and Jónasson: Improving HIV infant diagnosis supply chains ec3 (Details) (i) Denote the random number of samples for a given shipment from clinic i by X i . At any given time the probability of a transportation opportunity arriving before the next sample is denoted by
. Hence, the batch size can be modeled as geom(
), i.e. the number of trials before a success, where success is the next arrival being a transportation opportunity. Then the expectation and variance of X i can be written as;
(ii) Denote the random size of the sample shipments arriving at lab j by X j . Since the lab receives sample shipments from a number of clinics, the size of the arriving shipments depends partly on the frequency of transportation opportunities from each clinic. That is, the distribution of X j given by the distributional mixture X j ∼ X i with probability
. Hence, at the lab level the properties of the arrival batch distribution are as follows:
e-companion to Deo, Gallien, and Jónasson: Improving HIV infant diagnosis supply chains (iii) By assumption, the interarrival times of clinic shipments arriving at the lab, Y j , is assumed to have the property that SCV [Y j ] is equal to 1.
(iv) Hence the approximation given in (EC.1) becomes:
2) we get:
, representing the average number of samples not yet a part of a fully formed batch. If we denote the number of samples waiting to form a processing batch at lab j and time t by Z j (t), we get:
(vii) Substituting the results from (EC.5) and (EC.6) into (EC.3) yields:
e-companion to Deo, Gallien, and Jónasson: Improving HIV infant diagnosis supply chains
With the additional assumption that transportation resources γ i are distributed so that the average clinic batch size
= E is about constant for all i, then the expression above becomes:
(ix) Finally, applying Little's law and adding the expected post processing delay yields an approximation of the lab cycle time as a univariate function of utilization:
EC.4. Calculating α ju and β ju
As explained above the estimate of the total lab cycle time needs to be approximated by linear functions in order to formulate the problem as a MIP. In the optimization models derived in §5.2 and §5.3, the optimal solutions are achieved by strategically reducing lab cycle time. In light of this a conservative approximation of the convex lab cycle time function is one that approximates it using line segments between its functional values giving an upper bound, as opposed to using tangents (found by using the derivative of the function) which would give a lower bound.
The approximation algorithm we employ is based on the functional-values algorithm presented in Yang and Goh (1997) . Figure EC .1 shows how increasing the number of iterations improves the approximation for typical EID lab with one server.
EC.5. Parameter estimation for ϕ tb
To incorporate the ϕ tb function in the optimization formulation we must first assume a distributional family. We use maximum likelihood to fit 9 different two-parameter families of probability distributions to the Mozambique data for the T AT i data for each clinic. The log-normal distribution has the best fit in terms of log likelihood numbers and is therefore chosen as the distributional family for turnaround times in the MIP formulation. To be able to calculate the ϕ tb function we now only require an approximation for the second moment of the distribution, as the first is determined in constraints of the OLA optimization problem in §5.2. The fitted distributions have a fairly constant second distributional parameter (SCV 0.11) and so we parsimoniously assume the second parameter to be independent of the first and constant. Note that the methodology can easily incorporate other approximations for the second moment. We considered both empirical and theoretical approaches but found this to be the simplest justifiable assumption. §6.4 EC.6.1. The nature of OCA as a function of utilization. Each row shows the results of the optimization model for various levels of utilization, shown in the first column. The next 5 column groups show the results by lab, while the final 3 columns contain national averages. In Tables EC.4 and EC.5 we provide sensitivity analysis of Table 8 . They describe the nature of the OCA as the network diameter increases for a 5% decreased utilization and a 5% increased utilization, respectively. Note that as transportation times gradually increase, additional labs are opened later when utilization is high. This is due to the pooling benefits of consolidation being more substantial for higher utilization, and thus outweighing the increased transportation times for longer. 
EC.6. Extra figures and tables for
